Forskolin is a potent activator of adenylate cyclase, which catalyzes the conversion of ATP to cAMP, a second messenger that initiates a cascade of intracellular events leading to the activation of protein kinase A (PKA). This kinase can potentially phosphorylate a wide range of substrates, including proteins like C17orf58, thereby influencing their activity. Similarly, isoproterenol targets beta-adrenergic receptors, resulting in enhanced cAMP levels and PKA activation, suggesting a shared pathway with Forskolin. Ionomycin, by elevating intracellular calcium levels, can trigger the activation of calcium-dependent proteins, which may have downstream effects on proteins akin to C17orf58. PMA simulates diacylglycerol (DAG), activating protein kinase C (PKC), which is known for its role in phosphorylating serine and threonine on specific substrates, possibly affecting the function of various proteins.
Epigenetic modulators such as 5-Azacytidine and Trichostatin A (TSA) alter the expression pattern of genes. 5-Azacytidine leads to DNA hypomethylation, potentially upregulating the expression of numerous genes, while TSA inhibits histone deacetylases, which can result in a more transcriptionally active chromatin state, impacting the expression levels of proteins. Sodium orthovanadate serves as an inhibitor of protein tyrosine phosphatases, thereby possibly prolonging tyrosine phosphorylation signaling which might influence protein activities, including those similar to C17orf58. Compounds such as rapamycin, which inhibits the mammalian target of rapamycin (mTOR) pathway, can alter protein synthesis and degradation, thereby potentially affecting the stability and function of proteins. Antioxidants like Epigallocatechin gallate (EGCG) and Curcumin can exert modulatory effects on signaling pathways through their impact on oxidative stress and inflammation, which may in turn affect protein functionality.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium, which can activate calcium-dependent proteins that may interact with or modify C17orf58. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC, which can phosphorylate C17orf58 or associated proteins, modulating its activity. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Incorporates into RNA and DNA, leading to DNA hypomethylation, which can alter gene expression and indirectly affect C17orf58 expression levels. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Inhibits histone deacetylases, potentially increasing transcription of genes including that of C17orf58. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Inhibits tyrosine phosphatases, which can enhance tyrosine phosphorylation signaling pathways related to C17orf58 activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Activates beta-adrenergic receptors, increasing cAMP and activating PKA, which may influence C17orf58 phosphorylation and activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Regulates gene expression through its receptors, which may include transcriptional control of C17orf58. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Has antioxidant properties that can affect signaling pathways and potentially modulate C17orf58 activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog that activates PKA, which could influence the phosphorylation state of C17orf58. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, which can affect protein synthesis and autophagy processes that may involve C17orf58. | ||||||